November 4, 2025 - 04:55

In the third quarter of 2025, Palantir Technologies reported an impressive revenue growth of 63%, showcasing the company’s robust performance in the data analytics sector. This significant uptick can be attributed to the increasing demand for advanced data solutions across various industries, including government and commercial sectors. The company has successfully expanded its customer base and enhanced its product offerings, allowing it to capitalize on the growing trend of data-driven decision-making.
Despite the strong revenue figures, analysts express concerns regarding the valuation of Palantir's stock. The rapid growth in revenue has not translated into a proportional increase in stock value, leading to debates about whether the shares are overvalued in the current market. Investors are cautious, weighing the company's potential for sustained growth against its current market capitalization. As Palantir continues to innovate and expand its services, the stock's performance will be closely monitored by both analysts and investors alike.
July 10, 2026 - 04:47
Baker Hughes CEO: Continued business tailwinds with the need for power generation and LNGLorenzo Simonelli, the chief executive of Baker Hughes, appeared on `Power Lunch` to discuss the company`s outlook, pointing to sustained business tailwinds fueled by the growing need for power...
July 9, 2026 - 04:31
The Software Business Model Is Running Out of Time—and So Are Software StocksThe era of easy money for traditional software companies is coming to an end, and Wall Street is starting to panic. According to analysts at Stifel, the old ways of selling software-think long-term...
July 8, 2026 - 00:07
George E. Johnson Sr., founder of a pioneering Black hair care business, dies at 99George E. Johnson Sr., the visionary entrepreneur who built a multimillion dollar hair care empire and broke racial barriers on Wall Street, has died. He was 99. His family confirmed he passed away...
July 7, 2026 - 02:47
Medtronic recalls heart valve delivery system due to safety riskMedtronic has announced a recall for a specific heart valve delivery system, citing a safety risk that could affect patients. The recall involves the company`s Evolut FX and Evolut PRO+ delivery...